BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 5715475)

  • 1. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on antituberculous drug resistance among pulmonary tuberculosis patients at the national sanatoria in Kyushu district. 4. The primary and the secondary antituberculous agents].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1120-4. PubMed ID: 5710123
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic effects of secondary antitubercular agents at our hospital].
    Nakayama K; Hayashida M; Ishihara M; Ijichi F; Obata Y
    Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical problems of resistance to secondary antitubercular agents].
    Baba H; Takahashi R; Nakai T; Torii R; Yo I
    Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
    Zierski M
    Bull Int Union Tuberc; 1968 Dec; 41():194-200. PubMed ID: 4303863
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].
    Tsukamura M
    Kekkaku; 1971 Oct; 46(10):405-8. PubMed ID: 4112456
    [No Abstract]   [Full Text] [Related]  

  • 8. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of pulmonary tuberculosis in its current aspects].
    Gartmann JC
    Bibl Tuberc; 1965; 20():59-70. PubMed ID: 4291161
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evolution of antibiograms of bacilli persisting under treatment in the sanatorium].
    Marion L
    Rev Tuberc Pneumol (Paris); 1967; 31(6):785-808. PubMed ID: 4317451
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary drug resistance of Mycobacterium tuberculosis to 2d line preparations].
    Fedotova ZN; Gur'ian IE; Kochetov BI
    Probl Tuberk; 1972; 50(11):21-4. PubMed ID: 4630564
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 14. [Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
    Bialik IB
    Antibiotiki; 1971 Feb; 16(2):184-8. PubMed ID: 4326728
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current questions in the treatment of patients with chronic destructive pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Khutorskaia VD
    Klin Med (Mosk); 1976 Dec; 54(12):72-8. PubMed ID: 189127
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic effect of minor antituberculosis drugs on advanced pulmonary tuberculosis.
    Ando M
    Nagoya J Med Sci; 1967 Jan; 29(3):261-70. PubMed ID: 6074943
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tuberculostatic preparations of the 2d series in the clinical treatment of pulmonary tuberculosis].
    Kaminskaia AA; Utkin VV; Korotaev GA; Golitsina LV
    Probl Tuberk; 1967; 45(5):29-33. PubMed ID: 5617941
    [No Abstract]   [Full Text] [Related]  

  • 18. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
    Sirota DS; Man'kovetskiĭ EF; Koĭfman SG; Vatsyk MZ
    Probl Tuberk; 1974; (10):17-9. PubMed ID: 4370967
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients.
    Mital OP; Agarwala MC; Singh SK
    Indian J Chest Dis; 1967 Oct; 9(4):196-206. PubMed ID: 4323543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.